Stroke
- PMID: 18468545
- DOI: 10.1016/S0140-6736(08)60694-7
Stroke
Abstract
Stroke is the second most common cause of death and major cause of disability worldwide. Because of the ageing population, the burden will increase greatly during the next 20 years, especially in developing countries. Advances have occurred in the prevention and treatment of stroke during the past decade. For patients with acute stroke, management in a stroke care unit, intravenous tissue plasminogen activator within 3 h or aspirin within 48 h of stroke onset, and decompressive surgery for supratentorial malignant hemispheric cerebral infarction are interventions of proven benefit; several other interventions are being assessed. Proven secondary prevention strategies are warfarin for patients with atrial fibrillation, endarterectomy for symptomatic carotid stenosis, antiplatelet agents, and cholesterol reduction. The most important intervention is the management of patients in stroke care units because these provide a framework within which further study might be undertaken. These advances have exposed a worldwide shortage of stroke health-care workers, especially in developing countries.
Comment in
-
Secondary prevention of stroke.Lancet. 2008 Sep 20;372(9643):1035; author reply 1036. doi: 10.1016/S0140-6736(08)61437-3. Lancet. 2008. PMID: 18805325 No abstract available.
-
Secondary prevention of stroke.Lancet. 2008 Sep 20;372(9643):1036; author reply 1036. doi: 10.1016/S0140-6736(08)61438-5. Lancet. 2008. PMID: 18805327 No abstract available.
Similar articles
-
The intensive care management of acute ischemic stroke: an overview.Intensive Care Med. 2014 May;40(5):640-53. doi: 10.1007/s00134-014-3266-z. Intensive Care Med. 2014. PMID: 24658914 Review.
-
Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke.Lancet. 2011 May 14;377(9778):1681-92. doi: 10.1016/S0140-6736(11)60516-3. Lancet. 2011. PMID: 21571151 Review.
-
Warfarin for atrial fibrillation: the end of an era?Lancet Neurol. 2004 May;3(5):305-8. doi: 10.1016/S1474-4422(04)00738-0. Lancet Neurol. 2004. PMID: 15099545 Review.
-
[Stroke prevention].Ther Umsch. 2003 Sep;60(9):521-6. doi: 10.1024/0040-5930.60.9.521. Ther Umsch. 2003. PMID: 14579620 Review. German.
-
Differences in medical and surgical therapy for stroke prevention between leading experts in North America and Western Europe.Stroke. 1998 Feb;29(2):339-45. doi: 10.1161/01.str.29.2.339. Stroke. 1998. PMID: 9472871
Cited by
-
Inflammation and endothelial function relevant genetic polymorphisms, carotid atherosclerosis, and vascular events in high-risk stroke population.Front Neurol. 2024 May 16;15:1405183. doi: 10.3389/fneur.2024.1405183. eCollection 2024. Front Neurol. 2024. PMID: 38827573 Free PMC article.
-
BDNF Signaling in Vascular Dementia and Its Effects on Cerebrovascular Dysfunction, Synaptic Plasticity, and Cholinergic System Abnormality.J Lipid Atheroscler. 2024 May;13(2):122-138. doi: 10.12997/jla.2024.13.2.122. Epub 2024 Feb 22. J Lipid Atheroscler. 2024. PMID: 38826183 Free PMC article. Review.
-
A bibliometric analysis of acupuncture for cerebral infarction from 1993 to 2023.Front Neurol. 2024 May 2;15:1386164. doi: 10.3389/fneur.2024.1386164. eCollection 2024. Front Neurol. 2024. PMID: 38756219 Free PMC article.
-
Development of insomnia in patients with stroke: A systematic review and meta-analysis.PLoS One. 2024 Apr 10;19(4):e0297941. doi: 10.1371/journal.pone.0297941. eCollection 2024. PLoS One. 2024. PMID: 38598535 Free PMC article.
-
UPLC-MS based metabonomics revealed the protective effects of Buyang Huanwu decoction on ischemic stroke rats.Toxicol Res (Camb). 2024 Mar 31;13(2):tfae052. doi: 10.1093/toxres/tfae052. eCollection 2024 Apr. Toxicol Res (Camb). 2024. PMID: 38567035
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous